Browsing Category

Primary Progressive MS (PPMS)

Showing 3 Result(s)

Professor Neil Robertson: Leading Neurologist and Researcher

Professor Neil Robertson’s contributions to neurology and neurological research have not only advanced our understanding of complex disorders like multiple sclerosis but also shaped the landscape of neurological healthcare in Wales and beyond. His research and clinical work represent a commitment to both scientific discovery and compassionate care, offering hope to patients and families affected by neurological conditions. As he continues to lead new studies and mentor future neurologists, his impact will undoubtedly continue to be felt across the fields of neurology, genetics, and patient advocacy.

Progressive Multifocal Leukoencephalopathy (PML)

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications.

Therapies for Multiple Sclerosis

Multiple sclerosis is a complex and challenging condition to manage, but a wide range of therapies offers hope for patients. From disease-modifying drugs like Alemtuzumab and Anti-CD20 therapies to natural approaches such as sun therapy, each treatment targets different aspects of the disease.